Literature DB >> 33398719

If DILI Is Suspected, Don't Dally.

Aamer Abbass1, Sameen Khalid2, Umer Farooq3, Neal Rakov2, Joshua Hanson4, David Martin4, Denis McCarthy2.   

Abstract

Keywords:  Atovaquone; Atovaquone-proguanil; Drug-induced; Hepatotoxicity

Year:  2021        PMID： 33398719     DOI： 10.1007/s10620-020-06730-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Acute hepatitis and atovaquone/proguanil.

Authors:  Matthias Grieshaber; Jürg Lämmli; Louis Marcus
Journal:  J Travel Med       Date:  2005 Sep-Oct       Impact factor: 8.490

2.  Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.

Authors:  Mikio Kimura; Michiko Koga; Tadashi Kikuchi; Toshiyuki Miura; Haruhiko Maruyama
Journal:  Parasitol Int       Date:  2012-03-29       Impact factor: 2.230

3.  Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia.

Authors:  L J Epstein; Z Mohsenifar; E S Daar; V Yeh; R D Meyer
Journal:  Am J Med Sci       Date:  1994-07       Impact factor: 2.378

Review 4.  Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States.

Authors:  Paul H Hayashi
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

Review 5.  RUCAM in Drug and Herb Induced Liver Injury: The Update.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923
  5 in total
  2 in total

1.  Structure-activity relationships of Toxoplasma gondii cytochrome bc1 inhibitors.

Authors:  P Holland Alday; Aaron Nilsen; J Stone Doggett
Journal:  Expert Opin Drug Discov       Date:  2022-08-08       Impact factor: 7.050

Review 2.  Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature.

Authors:  Joseph William Clinton; Sara Kiparizoska; Soorya Aggarwal; Stephanie Woo; William Davis; James H Lewis
Journal:  Drug Saf       Date:  2021-09-17       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.